Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 223
Filter
1.
Regul Toxicol Pharmacol ; 133: 105194, 2022 Aug.
Article in English | MEDLINE | ID: mdl-35690181

ABSTRACT

The deuterium kinetic isotope effect has been used to affect the cytochrome P450 metabolism of the deuterated versions of substances. This study compares the pharmacokinetics of caffeine, a Generally Recognized As Safe food and beverage ingredient, versus d9-caffeine, a potential caffeine alternative, and their respective metabolites at two dose levels in 20 healthy adults. A single dose of 50 mg or 250 mg of caffeine, or a molar-equivalent dose of d9-caffeine, were orally administered in solution with blood samples collected for up to 48 h post-dose. Plasma concentrations of parent and metabolites were analyzed using validated LC-MS/MS methods. Both d9-caffeine and caffeine were rapidly absorbed; however, d9-caffeine exhibited a higher (ca. 29%-43%) Cmax and 4-5-fold higher AUClast than caffeine, and lower Cmax, lower AUClast, and a 5-10-fold reduction in the relative exposure to the active metabolites of caffeine. Results were consistent in normal and rapid metabolizers, and both substances were well tolerated.


Subject(s)
Caffeine , Adult , Area Under Curve , Caffeine/analogs & derivatives , Caffeine/pharmacokinetics , Chromatography, Liquid , Cross-Over Studies , Cytochrome P-450 Enzyme System , Double-Blind Method , Healthy Volunteers , Humans , Tandem Mass Spectrometry
2.
Mol Pharmacol ; 101(3): 154-167, 2022 03.
Article in English | MEDLINE | ID: mdl-34969831

ABSTRACT

Alzheimer's disease is a multifactorial neurodegenerative disorder. Since cholinergic deficit is a major factor in this disease, two molecular targets for its treatment are the acetylcholinesterase (AChE) and the nicotinic acetylcholine receptors (nAChRs). Given that caffeine is a natural compound that behaves as an AChE inhibitor and as a partial agonist of nAChRs, the aim of this work was to synthetize more potent bifunctional caffeine analogs that modulate these two molecular targets. To this end, a theophylline structure was connected to a pyrrolidine structure through a methylene chain of different lengths (3 to 7 carbon atoms) to give compounds 7-11 All caffeine derivatives inhibited the AChE, of which compound 11 showed the strongest effect. Electrophysiological studies showed that all compounds behave as agonists of the muscle and the neuronal α7 nAChR with greater potency than caffeine. To explore whether the different analogs could affect the nAChR conformational state, the nAChR conformational-sensitive probe crystal violet (CrV) was used. Compounds 9 and 10 conduced the nAChR to a different conformational state comparable with a control nAChR desensitized state. Finally, molecular docking experiments showed that all derivatives interacted with both the catalytic and anionic sites of AChE and with the orthosteric binding site of the nAChR. Thus, the new synthetized compounds can inhibit the AChE and activate muscle and α7 nAChRs with greater potency than caffeine, which suggests that they could be useful leaders for the development of new therapies for the treatment of different neurologic diseases. SIGNIFICANCE STATEMENT: In this work we synthetized caffeine derivatives which can inhibit acetylcholinesterase and activate both muscle and α7 nicotinic acetylcholine receptors (nAChRs) with higher potency than caffeine. These analogs can be divided into two groups: a non-desensitizing and a desensitizing nAChR group. From the nAChR non-desensitizing group, we propose compound 11 as the most interesting analog for further studies since it inhibits acetylcholinesterase with the highest potency and activates the nAChRs in the picomolar range without inducing receptor desensitization.


Subject(s)
Caffeine/analogs & derivatives , Caffeine/chemical synthesis , alpha7 Nicotinic Acetylcholine Receptor/agonists , alpha7 Nicotinic Acetylcholine Receptor/metabolism , Animals , Caffeine/metabolism , Caffeine/pharmacology , Electrophorus , HEK293 Cells , Humans , Molecular Docking Simulation/methods , Protein Structure, Secondary , Torpedo , alpha7 Nicotinic Acetylcholine Receptor/chemistry
3.
J Biomol Struct Dyn ; 40(11): 4893-4904, 2022 07.
Article in English | MEDLINE | ID: mdl-33390094

ABSTRACT

Cafaminol, also known as methylcoffanolamine, is a vasoconstrictor and anticatarrhal of the methylxanthine family, which is used as a nasal decongestant. This study aimed to investigate the interaction mechanisms of human serum albumin (HSA) with Cafaminol, through several spectroscopic (fluorescence quenching, UV-visible absorption, and circular dichroism (CD) spectroscopies) and molecular modeling techniques. Stern-Volmer plots were employed to specify the fluorescence quenching mechanism, while the simulation methods were utilized to deduce the approximate binding position of Cafaminol on HSA. On the other hand, thermodynamic parameters, enthalpy and entropy changes, were determined to be, respectively, -105.88 (kJ mol-1) and -282.34 (J mol-1 K-1), using the Van't Hoff equation and analyzed later to specify the main acting forces between Cafaminol and HSA. Overall results revealed the binding of Cafaminol to the site I of HSA, as a result of an enthalpy-driven process, mainly through the van der Waals and hydrogen bonding interactions. Static quenching mechanism was found to be responsible for the fluorescence quenching of HSA in the Cafaminol presence, while the number of binding sites and apparent binding constant were measured accordingly. Docking results proposed that Cafaminol and HSA interact with a binding free energy (ΔG) of -6.5 kcal mol-1Communicated by Ramaswamy H. Sarma.


Subject(s)
Serum Albumin, Human , Serum Albumin , Binding Sites , Caffeine/analogs & derivatives , Circular Dichroism , Humans , Molecular Docking Simulation , Protein Binding , Serum Albumin/chemistry , Serum Albumin, Human/metabolism , Spectrometry, Fluorescence , Spectrum Analysis , Thermodynamics
4.
Int Immunopharmacol ; 100: 108090, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34507108

ABSTRACT

BACKGROUND: Immunomodulatory therapies are claimed to enhance antimicrobial immunity and counterbalance antimicrobial resistance mechanisms of pathogenic bacteria. PURPOSE: To investigate whether caffeine can be useful for control of inflammation derived from experimental systemic infection with Listeria monocytogenes. METHODS: Peritoneal macrophages (pMØ) from Swiss mice were cultured with caffeine in 96-well plates, and then infected with virulent L. monocytogenes 619. In another experiment, the pMØ were first infected with the bacterium and then treated with caffeine. Swiss mice were inoculated intraperitoneally with L. monocytogenes and then treated intravenously with caffeine (0.05; 0.5 or 5 mg/Kg). RESULTS: Caffeine did not exert direct antibacterial activity in vitro against L. monocytogenes. Macrophages exposed to caffeine before or after infection with L. monocytogenes had increased cell viability, although the intracellular bacterial loads were similar to the control groups. Caffeine treatments of Swiss mice reduced leukocyte infiltration into the peritoneal cavity after L. monocytogenes infection. However, the bacterial burden was reduced in the spleen and liver. The mRNA expressions of IL-1ß, IL-6 and the enzyme inducible nitric oxide synthase (iNOS) were reduced whereas IL-10 was increased. CONCLUSION: Caffeine has an anti-infectious potential and ameliorated infection-derived inflammation following experimental infection with L. monocytogenes.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Caffeine/pharmacology , Inflammation/drug therapy , Listeria monocytogenes/pathogenicity , Listeriosis/drug therapy , Macrophages, Peritoneal/drug effects , Animals , Caffeine/analogs & derivatives , Cells, Cultured , Chemotaxis, Leukocyte/drug effects , Disease Models, Animal , Host-Pathogen Interactions , Inflammation/immunology , Inflammation/metabolism , Inflammation/microbiology , Inflammation Mediators/metabolism , Interleukin-1beta/genetics , Interleukin-1beta/metabolism , Interleukin-6/genetics , Interleukin-6/metabolism , Listeria monocytogenes/immunology , Listeriosis/immunology , Listeriosis/metabolism , Listeriosis/microbiology , Macrophages, Peritoneal/immunology , Macrophages, Peritoneal/metabolism , Macrophages, Peritoneal/microbiology , Mice , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/metabolism , Virulence
5.
Bioorg Chem ; 111: 104900, 2021 06.
Article in English | MEDLINE | ID: mdl-33894429

ABSTRACT

Due to their unique pharmacological characteristics, methylxanthines are known as therapeutic agents in a fascinating range of medicinal scopes. In this report, we aimed to examine some biological effects of previously synthesized 8-alkylmercaptocaffeine derivatives. Cytotoxic and antioxidative activity of 8-alkylmercaptocaffeine derivatives were measured in malignant A549, MCF7, and C152 cell lines. Assessment of cGMP levels and caspase-3 activity were carried out using a colorimetric competitive ELISA kit. Computational approaches were employed to discover the inhibitory mechanism of synthesized compounds. Among the twelve synthesized derivatives, three compounds (C1, C5, and C7) bearing propyl, heptyl, and 3-methyl-butyl moieties showed higher and more desirable cytotoxic activity against all the studied cell lines (IC50 < 100 µM). Furthermore, C5 synergistically enhanced cisplatin-induced cytotoxicity in MCF-7 cells (CI < 1). Both C5 and C7 significantly increased caspase-3 activity and intracellular cGMP levels at specific time intervals in all studied cell lines (P < 0.05). However, these derivatives did not elevate LDH leakage (P > 0.05) and exhibited no marked ameliorating effects on oxidative damage (P > 0.05). Computational studies showed that H-bond formation between the nitrogen atom in pyrazolo[4,3-D] pyrimidine moiety with Gln817 and creating a hydrophobic cavity result in the stability of the alkyl group in the PDE5A active site. We found that synthesized 8-alkylmercaptocaffeine derivatives induced cell death in different cancer cells through the cGMP pathway. These findings will help us to get a deeper insight into the role of methylxanthines as useful alternatives to conventional cancer therapeutics.


Subject(s)
Antineoplastic Agents/pharmacology , Antioxidants/pharmacology , Caffeine/pharmacology , Molecular Docking Simulation , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Antioxidants/chemical synthesis , Antioxidants/chemistry , Biphenyl Compounds/antagonists & inhibitors , Caffeine/analogs & derivatives , Caffeine/chemistry , Cell Proliferation/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , Humans , Molecular Structure , Picrates/antagonists & inhibitors , Structure-Activity Relationship
6.
Chemistry ; 26(67): 15528-15537, 2020 Dec 01.
Article in English | MEDLINE | ID: mdl-32902006

ABSTRACT

The organometallic AuI bis-N-heterocyclic carbene complex [Au(9-methylcaffeine-8-ylidene)2 ]+ (AuTMX2 ) was previously shown to selectively and potently stabilise telomeric DNA G-quadruplex (G4) structures. This study sheds light on the molecular reactivity and mode of action of AuTMX2 in the cellular context using mass spectrometry-based methods, including shotgun proteomics in A2780 ovarian cancer cells. In contrast to other metal-based anticancer agents, this organogold compound is less prone to form coordinative bonds with biological nucleophiles and is expected to exert its drug effects mainly by non-covalent interactions. Global protein expression changes of treated cancer cells revealed a multimodal mode of action of AuTMX2 by alterations in the nucleolus, telomeres, actin stress-fibres and stress-responses, which were further supported by pharmacological assays, fluorescence microscopy and cellular accumulation experiments. Proteomic data are available via ProteomeXchange with identifier PXD020560.


Subject(s)
Antineoplastic Agents , Gold , Organometallic Compounds , Ovarian Neoplasms , Antineoplastic Agents/pharmacology , Caffeine/analogs & derivatives , Caffeine/chemistry , Caffeine/pharmacology , Cell Line, Tumor , Female , Gold/chemistry , Gold/pharmacology , Humans , Methane/analogs & derivatives , Methane/chemistry , Methane/pharmacology , Organometallic Compounds/pharmacology , Ovarian Neoplasms/drug therapy , Proteomics
7.
Neuroscience ; 422: 32-43, 2019 12 01.
Article in English | MEDLINE | ID: mdl-31678341

ABSTRACT

A stroke-like event follows seizures which may be responsible for the postictal state and a contributing factor to the development of seizure-induced brain abnormalities and behavioral dysfunction associated with epilepsy. Caffeine is the world's most popular drug with ∼85% of people in the USA consuming it daily. Thus, persons with epilepsy are likely to have caffeine in their body and brain during seizures. This preclinical study investigated the effects of acute caffeine on local hippocampal tissue oxygenation pre and post seizure. We continuously measured local oxygen levels in the CA1 region of the hippocampus and utilized the electrical kindling model in rats. Rats were acutely administered either caffeine, or one of its metabolites, or agonists and antagonists at adenosine sub-receptor types or ryanodine receptors prior to the elicitation of seizures. Acute caffeine administration caused a significant drop in pre-seizure hippocampal pO2. Following a seizure, caffeine, as well as two of its metabolites paraxanthine, and theophylline, increased the time below the severe hypoxic threshold (10 mmHg). Likewise, the specific A2A receptor antagonist, SCH-58261, mimicked caffeine by causing a significant drop in pre-seizure pO2 and the area and time below the severe hypoxic threshold. Moreover, the A2A receptor agonist, CGS-21680 was able to prevent the effect of both caffeine and SCH-58261 adding further evidence that caffeine is likely acting through the A2A receptor. Clinical tracking and investigations are needed to determine the effect of caffeine on postictal symptomology and blood flow in persons with epilepsy.


Subject(s)
Caffeine/adverse effects , Hypoxia/physiopathology , Receptors, Adenosine A2/physiology , Seizures/physiopathology , Adenosine/analogs & derivatives , Adenosine/pharmacology , Animals , CA1 Region, Hippocampal/metabolism , Caffeine/analogs & derivatives , Caffeine/antagonists & inhibitors , Dose-Response Relationship, Drug , Hypoxia/complications , Kindling, Neurologic/drug effects , Male , Oxygen/metabolism , Phenethylamines/pharmacology , Pyrimidines/antagonists & inhibitors , Pyrimidines/pharmacology , Rats , Receptors, Adenosine A2/drug effects , Seizures/complications , Triazoles/antagonists & inhibitors , Triazoles/pharmacology
8.
Rapid Commun Mass Spectrom ; 33(23): 1792-1803, 2019 Dec 15.
Article in English | MEDLINE | ID: mdl-31351020

ABSTRACT

RATIONALE: Novel bifunctional compounds composed of a caffeine scaffold attached to nicotine (C8 -6-N), 1-aminoindan (C8 -6-I), or caffeine (C8 -6-C8 ) were designed as therapeutics or diagnostics for Parkinson's disease (PD). In order to probe their pharmacological and toxicological profile, an appropriate analytical method is required. The goal of this study is to establish a tandem mass spectrometric fingerprint for the development of quantitative and qualitative methods that will aid future assessment of the in vitro and in vivo absorption, distribution, metabolism, excretion (ADME) and pharmacokinetic properties of these lead bifunctional compounds for PD. METHODS: Accurate mass measurement was performed using a hybrid quadrupole orthogonal time-of-flight mass spectrometer while multistage MS/MS and MS3 analyses were conducted using a triple quadrupole linear ion trap mass spectrometer. Both instruments are equipped with an electrospray ionization (ESI) source and were operated in the positive ion mode. The source and compound parameters were optimized for all three tested bifunctional compounds. RESULTS: The MS/MS analysis indicates that the fragmentation of C8 -6-N and C8 -6-I is driven by the dissociation of the nicotine and 1-aminoindan moieties, respectively, but not caffeine. A significant observation in the MS/MS fragmentation of C8 -6-C8 suggests that a previously reported loss of acetaldehyde during caffeine dissociation is instead a loss of CO2 . CONCLUSIONS: The collision-induced tandem mass spectrometry (CID-MS/MS) analysis of these novel bifunctional compounds revealed compound-specific diagnostic product ions and neutral losses for all three tested bifunctional compounds. The established MS/MS fingerprint will be applied to the future development of qualitative and quantitative methods.


Subject(s)
Caffeine/analogs & derivatives , Indans/chemistry , Nicotine/analogs & derivatives , Tandem Mass Spectrometry/methods , Humans , Parkinson Disease/diagnosis , Parkinson Disease/drug therapy , Spectrometry, Mass, Electrospray Ionization/methods
9.
J Inorg Biochem ; 198: 110749, 2019 09.
Article in English | MEDLINE | ID: mdl-31200320

ABSTRACT

Three Pt(II) complexes containing the natural ligands curcumin and caffeine, namely [Pt(curc)(PPh3)2]Cl (1), [PtCl(curc)(DMSO)] (2) (curc = deprotonated curcumin) and trans-[Pt(caffeine)Cl2(DMSO)] (3), were synthesized and fully characterized. The data obtained suggest that, for both 1 and 2, the anion of curcumin is coordinated to the platinum ion via the oxygen atoms of the ß-diketonate moiety. Spectroscopic features reveal that in 2 and 3, a DMSO molecule is S-bonded to the metal centre. For 3, all data indicate a square-planar geometry formed by a 9-N bonded caffeine, two trans chloride anions and a DMSO. The three complexes undergo changes in solution upon incubation for 24 h; 1 and 2 release curcumin while 3 isomerizes from trans to cis configuration. The DNA-binding and cytotoxic properties of 1-3 were evaluated in vitro. Despite their structural similarity, curcuminate-containing 1 and 2 exhibit distinct DNA interactions. While 1 appears to intercalate between nucleobase pairs, inducing the oxidative degradation of the biomolecule, 2 behaves as a groove binder, by means of electrostatic forces. Caffeine-containing 3 exhibits a behaviour that is comparable to that of 2. Complexes 1 and 2 showed moderate to high cytotoxicity and selectivity against several cancer cell lines, while 3 is inactive. Compounds 1 and 2 can be further activated by visible-light irradiation.


Subject(s)
Antineoplastic Agents/pharmacology , Caffeine/pharmacology , Coordination Complexes/pharmacology , Curcumin/pharmacology , DNA/metabolism , Animals , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/metabolism , Caffeine/analogs & derivatives , Caffeine/chemical synthesis , Caffeine/metabolism , Cattle , Cell Line, Tumor , Cisplatin/pharmacology , Coordination Complexes/chemical synthesis , Coordination Complexes/metabolism , Curcumin/analogs & derivatives , Curcumin/chemical synthesis , Curcumin/metabolism , Drug Screening Assays, Antitumor , Drug Stability , Humans , Ligands , Molecular Structure , Platinum/chemistry
10.
Molecules ; 23(11)2018 Oct 29.
Article in English | MEDLINE | ID: mdl-30380600

ABSTRACT

The antioxidant activity of molecules constitutes an important factor for the regulation of redox homeostasis and reduction of the oxidative stress. Cells affected by oxidative stress can undergo genetic alteration, causing structural changes and promoting the onset of chronic diseases, such as cancer. We have performed an in silico study to evaluate the antioxidant potential of two molecules of the zinc database: ZINC08706191 (Z91) and ZINC08992920 (Z20). Molecular docking, quantum chemical calculations (HF/6-31G**) and Pearson's correlation have been performed. Molecular docking results of Z91 and Z20 showed both the lower binding affinity (BA) and inhibition constant (Ki) values for the receptor-ligand interactions in the three tested enzymes (cytochrome P450-CP450, myeloperoxidase-MP and NADPH oxidase-NO) than the control molecules (5-fluorouracil-FLU, melatonin-MEL and dextromethorphan-DEX, for each receptor respectively). Molecular descriptors were correlated with Ki and strong correlations were observed for the CP450, MP and NO receptors. These and other results attest the significant antioxidant ability of Z91 and Z20, that may be indicated for further analyses in relation to the control of oxidative stress and as possible antioxidant agents to be used in the pharmaceutical industry.


Subject(s)
Antioxidants/chemistry , Caffeine/analogs & derivatives , Caffeine/chemistry , Enzymes/chemistry , Catalytic Domain , Computer Simulation , Enzymes/metabolism , Febuxostat/chemistry , Fluorouracil/chemistry , Hydroxyurea/analogs & derivatives , Hydroxyurea/chemistry , Molecular Docking Simulation , Quantum Theory
11.
ChemMedChem ; 13(22): 2408-2414, 2018 11 20.
Article in English | MEDLINE | ID: mdl-30203922

ABSTRACT

Three new gold(I)-coumarin-based trackable therapeutic complexes and two non-trackable analogues have been synthesised and fully characterised. They all display anti-proliferative properties on several types of cancer cell lines, including those of colon, breast, and prostate. Two complexes displayed significant anti-inflammatory effects; one displayed pro-inflammatory behaviour; this highlights the impact of the position of the fluorophore on the caffeine scaffold. Additionally, the three coumarin derivatives could be visualised in vitro by two-photon microscopy.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antineoplastic Agents/pharmacology , Caffeine/analogs & derivatives , Caffeine/pharmacology , Coordination Complexes/pharmacology , Coumarins/pharmacology , Anti-Inflammatory Agents/chemical synthesis , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/radiation effects , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Antineoplastic Agents/radiation effects , Caffeine/chemical synthesis , Caffeine/radiation effects , Cell Line, Tumor , Coordination Complexes/chemical synthesis , Coordination Complexes/chemistry , Coordination Complexes/radiation effects , Coumarins/chemical synthesis , Coumarins/chemistry , Coumarins/radiation effects , Fluorescence , Fluorescent Dyes/chemical synthesis , Fluorescent Dyes/chemistry , Fluorescent Dyes/pharmacology , Fluorescent Dyes/radiation effects , Gold/chemistry , HEK293 Cells , Humans , Microscopy, Fluorescence, Multiphoton/methods , Ultraviolet Rays
12.
Free Radic Res ; 52(6): 724-736, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29669446

ABSTRACT

A series of new di- and polyamine-caffeine analogues were synthesised and characterised by NMR, FT-IR, and MS spectroscopic methods. To access the stability of the investigated caffeine analogues, molecular dynamic simulations were performed in NAMD 2.9 assuming CHARMM36 force field. To evaluate the antioxidant capacity of new compounds, three different antioxidant assays were used, namely 1,1-diphenyl-2-picryl-hydrazyl free radical (DPPH•) scavenging activity, ferrous ions (Fe2+) chelating activity, and Fe3+→Fe2+reducing ability. In vitro, the ability of new derivatives to protect human erythrocytes against oxidative haemolysis induced by free radical from 2,2'-azobis(2-methylpropionamidine) dihydrochloride (AAPH) was estimated. The cytotoxic activity was tested using MCF-7 breast cancer cells and human erythrocytes. All compounds showed the antioxidant capacity depending mostly on their ferrous ions chelating activity. In the presence of AAPH, some derivatives were able to effectively inhibit the oxidative haemolysis. Two derivatives, namely 8-(methyl(2-(methylamino)ethyl)-amino)caffeine and 8-(methyl(3-(methylamino)propyl)amino)caffeine, showed cytotoxic activity against MCF-7 breast cancer cells but not against human erythrocytes. Therefore, it is concluded that the selected di- and polyamine caffeine analogues, depending on their chemical structure, were able to minimise the oxidative stress and to inhibit the tumour cell growth. The confirmed antioxidant and cytotoxic properties of some caffeine derivatives make them attractive for potential applications in food or pharmaceutical industries.


Subject(s)
Antioxidants/pharmacology , Caffeine/pharmacology , Chelating Agents/pharmacology , Cytotoxins/pharmacology , Oxidants/antagonists & inhibitors , Amidines/antagonists & inhibitors , Amidines/pharmacology , Antioxidants/chemical synthesis , Biphenyl Compounds/antagonists & inhibitors , Biphenyl Compounds/chemistry , Caffeine/analogs & derivatives , Caffeine/chemical synthesis , Cell Survival/drug effects , Chelating Agents/chemical synthesis , Cytotoxins/chemical synthesis , Erythrocytes/drug effects , Hemolysis/drug effects , Humans , Inhibitory Concentration 50 , Iron/chemistry , MCF-7 Cells , Organ Specificity , Oxidants/pharmacology , Oxidation-Reduction , Picrates/antagonists & inhibitors , Picrates/chemistry , Polyamines/chemistry , Structure-Activity Relationship
13.
Curr Pharm Des ; 24(5): 576-594, 2018.
Article in English | MEDLINE | ID: mdl-28699538

ABSTRACT

About 132 thousand cases of melanoma (more severe type of skin cancer) were registered in 2014 according to the World Health Organization. This type of cancer significantly affects the quality of life of individuals. Caffeine has shown potential inhibitory effect against epithelial cancer. In this study, it was proposed to obtain new caffeine-based molecules with potential epithelial anticancer activity. For this, a training set of 21 molecules was used for pharmacophore perception procedures. Multiple linear regression analyses were used to propose mono-, bi-, tri-, and tetra-parametric models applied in the prediction of the activity. The generated pharmacophore was used to select 350 molecules available at the ZINCpharmer server, followed by reduction to 24 molecules, after selection using the Tanimoto index, yielding 10 molecules after final selection by predicted activity values > 1.5229. These ten molecules had better pharmacokinetic properties than the other ones used as reference and within the clinically significant limits. Only two molecules show minor hits of toxicity and were submitted to molecular docking procedures, showing BFE (binding free energy) values lower than the reference values. Statistical analyses indicated strong negative correlations between BFE and pharmacophoric properties (high influence on BFE lowering) and practically null correlation between BFE and BBB. The two most promising molecules can be indicated as candidates for further in vitro and in vivo analyzes.


Subject(s)
Antineoplastic Agents/pharmacology , Caffeine/pharmacology , Carcinoma, Ovarian Epithelial/drug therapy , Drug Design , Ovarian Neoplasms/drug therapy , Animals , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Caffeine/analogs & derivatives , Caffeine/chemistry , Carcinoma, Ovarian Epithelial/pathology , Drug Evaluation, Preclinical , Female , Humans , Molecular Docking Simulation , Ovarian Neoplasms/pathology , Rats , Statistics as Topic
14.
Pak J Biol Sci ; 20(2): 82-91, 2017.
Article in English | MEDLINE | ID: mdl-29022998

ABSTRACT

BACKGROUND: Caffeine, 1, 3, 7-trimethylxanthine is one of the xanthine derivatives that are for the most part utilized as a part of solutions as diuretics. The Cu (II) complexes have been synthesized from the N-heterocyclic carbene ligands. MATERIALS AND METHODS: The Cu (II) NHC complexes were characterized using analytical and spectral techniques. Antibacterial and antifungal activities of the Cu (II) NHC complexes were determined using the reported techniques. The SOD activity was assayed using nitrobluetetrazolium as O2 scavenger. RESULTS: The X-band ESR spectra of the copper complexes in DMSO solution at 300 and 77 K were recorded and their salient features are reported. The in vitro biological screening effects of the investigated compounds were tested against the bacterial species, Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Proteus vulgaris and Pseudomonas aeruginosa and fungal species, Aspergillus niger, Rhizopus stolonifer, Aspergillus flavus, Rhizoctonia bataicola and Candida albicans by serial dilution method. CONCLUSION: The Cu (II) complexes exhibit square planar geometry. A comparative study of inhibition values of the individual metals and their complexes indicate that the complexes exhibit higher antimicrobial activity than the individual metals. Superoxide dismutase and reducing power activities of the copper complexes have also been studied. Depending on the molecular structure, the Cu (II) NHC complex possess promising SOD mimetic activities. Further we are trying to explore more biological properties of Cu (II) NHC complexes in vitro and in vivo.


Subject(s)
Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/pharmacology , Antifungal Agents/chemical synthesis , Antifungal Agents/pharmacology , Caffeine/chemical synthesis , Caffeine/pharmacology , Copper/chemistry , Copper/pharmacology , Xanthines/chemical synthesis , Xanthines/pharmacology , Bacteria/drug effects , Bacteria/growth & development , Caffeine/analogs & derivatives , Free Radical Scavengers/chemical synthesis , Free Radical Scavengers/pharmacology , Fungi/drug effects , Fungi/growth & development , Microbial Sensitivity Tests , Molecular Mimicry , Molecular Structure , Structure-Activity Relationship , Superoxide Dismutase/chemistry
15.
BMC Anesthesiol ; 16(1): 121, 2016 12 03.
Article in English | MEDLINE | ID: mdl-27914476

ABSTRACT

BACKGROUND: Lidocaine is an approved local anesthetic and Class 1B antiarrhythmic with a number of ancillary properties. Our aim was to investigate lidocaine's vasoreactivity properties in intact versus denuded rat thoracic aortic rings, and the effect of inhibitors of nitric oxide (NO), prostenoids, voltage-dependent Kv and KATP channels, membrane Na+/K+ pump, and A2a and A2b receptors. METHODS: Aortic rings were harvested from adult male Sprague Dawley rats and equilibrated in an organ bath containing oxygenated, modified Krebs-Henseleit solution, pH 7.4, 37 °C. The rings were pre-contracted sub-maximally with 0.3 µM norepinephrine (NE), and the effect of increasing lidocaine concentrations was examined. Rings were tested for viability after each experiment with maximally dilating 100 µM papaverine. The drugs 4-aminopyridine (4-AP), glibenclamide, 5-hydroxydecanoate, ouabain, 8-(3-chlorostyryl) caffeine and PSB-0788 were examined. RESULTS: All drugs tested had no significant effect on basal tension. Lidocaine relaxation in intact rings was biphasic between 1 and 10 µM (Phase 1) and 10 and 1000 µM (Phase 2). Mechanical removal of the endothelium resulted in further relaxation, and at lower concentrations ring sensitivity (% relaxation per µM lidocaine) significantly increased 3.5 times compared to intact rings. The relaxing factor(s) responsible for enhancing ring relaxation did not appear to be NO- or prostacyclin-dependent, as L-NAME and indomethacin had little or no effect on intact ring relaxation. In denuded rings, lidocaine relaxation was completely abolished by Kv channel inhibition and significantly reduced by antagonists of the MitoKATP channel, and to a lesser extent the SarcKATP channel. Curiously, A2a subtype receptor antagonism significantly inhibited lidocaine relaxation above 100 µM, but not the A2b receptor. CONCLUSIONS: We show that lidocaine relaxation in rat thoracic aorta was biphasic and significantly enhanced by endothelial removal, which did not appear to be NO or prostacyclin dependent. The unknown factor(s) responsible for enhanced relaxation was significantly reduced by Kv inhibition, 5-HD inhibition, and A2a subtype inhibition indicating a potential role for crosstalk in lidocaine's vasoreactivity.


Subject(s)
Aorta, Thoracic/drug effects , KATP Channels/antagonists & inhibitors , Lidocaine/pharmacology , Potassium Channels, Voltage-Gated/antagonists & inhibitors , Vasodilation/drug effects , 4-Aminopyridine/pharmacology , Adenosine A2 Receptor Antagonists/pharmacology , Animals , Caffeine/analogs & derivatives , Caffeine/pharmacology , Decanoic Acids/pharmacology , Dose-Response Relationship, Drug , Epoprostenol/antagonists & inhibitors , Glyburide/pharmacology , Hydroxy Acids/pharmacology , In Vitro Techniques , Indomethacin/pharmacology , Lidocaine/antagonists & inhibitors , Male , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide/antagonists & inhibitors , Norepinephrine/pharmacology , Ouabain/pharmacology , Papaverine/pharmacology , Rats , Receptor Cross-Talk/drug effects , Receptor, Adenosine A2A/drug effects
16.
Bioorg Med Chem ; 24(19): 4759-4765, 2016 10 01.
Article in English | MEDLINE | ID: mdl-27567078

ABSTRACT

Mature neurotrophins as well as their pro forms are critically involved in the regulation of neuronal functions. They are signaling through three distinct types of receptors: tropomyosin receptor kinase family (TrkA/B/C), p75 neurotrophin receptor (p75(NTR)) and sortilin. Aberrant expression of p75(NTR) in the CNS is implicated in a variety of neurodegenerative diseases, including Alzheimer's disease. The goal of this work was to evaluate one of the very few reported p75(NTR) small molecule ligands as a lead compound for development of novel PET radiotracers for in vivo p75(NTR) imaging. Here we report that previously described ligand LM11A-24 shows significant inhibition of carbachol-induced persistent firing (PF) of entorhinal cortex (EC) pyramidal neurons in wild-type mice via selective interaction with p75(NTR). Based on this electrophysiological assay, the compound has very high potency with an EC50<10nM. We optimized the radiosynthesis of [(11)C]LM11A-24 as the first attempt to develop PET radioligand for in vivo imaging of p75(NTR). Despite some weak interaction with CNS tissues, the radiolabeled compound showed unfavorable in vivo profile presumably due to high hydrophilicity.


Subject(s)
Caffeine/analogs & derivatives , Positron-Emission Tomography/methods , Receptor, Nerve Growth Factor/metabolism , Animals , Caffeine/metabolism , Caffeine/pharmacokinetics , Carbon Radioisotopes/metabolism , Carbon Radioisotopes/pharmacokinetics , Central Nervous System/diagnostic imaging , Central Nervous System/metabolism , Mice, Inbred C57BL
17.
Bioorg Med Chem Lett ; 26(2): 540-544, 2016 Jan 15.
Article in English | MEDLINE | ID: mdl-26646217

ABSTRACT

The effects of different adenosine receptor antagonists and cyclic nucleotide phosphodiesterase (PDE) inhibitors on monoclonal antibody (mAb) titer and cell viability of murine hybridoma cells in culture were measured as part of our investigations to discover additives that enhance mAb production. Specific adenosine receptor antagonists and PDE inhibitors were found to enhance or decrease the titer of immunoglobulin G1 (IgG1) mAbs relative to negative controls, depending on the specific compound and cell line employed. The observed enhancements or decreases in IgG1 mAb titer appeared to be mainly due to an increase or decrease in specific productivity rates (ngmAb/cell), respectively. The different effects of the selective adenosine antagonists suggest that antagonism at the level of the adenosine A2A and A1 or the adenosine A3 receptors result in either enhancement or suppression of IgG1 mAb production by hybridoma cells. Overall, these studies have identified hitherto unknown activities of specific adenosine antagonists and PDE inhibitors which indicate they may have valuable roles as cell culture additives in industrial biomanufacturing processes designed to enhance the yields of mAbs or other recombinant proteins produced by mammalian cell culture procedures.


Subject(s)
Antibodies, Monoclonal, Murine-Derived/biosynthesis , Immunoglobulin G/biosynthesis , Phosphodiesterase Inhibitors/pharmacology , Purinergic P1 Receptor Antagonists/pharmacology , Animals , Antibodies, Monoclonal, Murine-Derived/pharmacology , Caffeine/analogs & derivatives , Caffeine/pharmacology , Cell Survival , Hybridomas , Mice
18.
Am J Ther ; 23(3): e757-65, 2016.
Article in English | MEDLINE | ID: mdl-24368612

ABSTRACT

Defibrotide is a polydisperse mixture of single-stranded oligonucleotides with many pharmacologic properties and multiple actions on the vascular endothelium. Responses to defibrotide and other vasodepressor agents were evaluated in the pulmonary vascular bed of the cat under conditions of controlled pulmonary blood flow and constant left atrial pressure. Lobar arterial pressure was increased to a high steady level with the thromboxane A2 analog U-46619. Under increased-tone conditions, defibrotide caused dose-dependent decreases in lobar arterial pressure without altering systemic arterial and left atrial pressures. Responses to defibrotide were significantly attenuated after the administration of the cyclooxygenase inhibitor sodium meclofenamate. Responses to defibrotide were also significantly attenuated after the administration of both the adenosine 1 and 2 receptor antagonists 8-cyclopentyl-1,3-dimethylxanthine and 8-(3-chlorostyryl)caffeine. Responses to defibrotide were not altered after the administration of the vascular selective adenosine triphosphate-sensitive potassium channel blocker U-37883A, or after the administration of the nitric oxide synthase inhibitor L-N-(1-iminoethyl)-ornithine. These data show that defibrotide has significant vasodepressor activity in the pulmonary vascular bed of the cat. They also suggest that pulmonary vasodilator responses to defibrotide are partially dependent on both the activation of the cyclooxygenase enzyme and adenosine 1 and 2 receptor pathways and independent of the activation of adenosine triphosphate-sensitive potassium channels or the synthesis of nitric oxide in the pulmonary vascular bed of the cat.


Subject(s)
Blood Pressure/drug effects , Endothelium, Vascular/drug effects , Polydeoxyribonucleotides/pharmacology , Pulmonary Circulation/drug effects , Vasodilator Agents/pharmacology , 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid/pharmacology , Adamantane/analogs & derivatives , Adamantane/pharmacology , Adenosine/antagonists & inhibitors , Animals , Caffeine/analogs & derivatives , Caffeine/pharmacology , Cats , Cyclooxygenase Inhibitors/pharmacology , Diuretics/pharmacology , Female , Male , Meclofenamic Acid/pharmacology , Morpholines/pharmacology , Nitric Oxide , Nitric Oxide Synthase/antagonists & inhibitors , Ornithine/analysis , Ornithine/pharmacology , Potassium Channel Blockers/pharmacology , Pulmonary Circulation/physiology , Purinergic P1 Receptor Antagonists/pharmacology , Theophylline/analogs & derivatives , Theophylline/pharmacology , Vascular Resistance , Vasoconstrictor Agents/pharmacology
19.
Neurochem Res ; 40(3): 531-41, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25503480

ABSTRACT

(E)-2-(1-hydroxyl-4-oxocyclohexyl) ethyl caffeine (HOEC), a naturally caffeic ester isolated from Incarvillea mairei, has been reported to possess anti-inflammatory activity by targeting 5-lipoxygenase. However, its other potential activities have yet to be explored. In this study, we measured antioxidant activity of HOEC using the DPPH free radical-scavenging assay. Then, we exposed rat pheochromocytoma (PC12) cells to hydrogen peroxide (H2O2)-induced damage and investigated the antioxidant activity of HOEC. Cell viability, lactate dehydrogenase (LDH) release, cellular morphology, Hoechst 33342 fluorescent staining, and apoptosis of the PC12 cells were assessed after treatment with 0.3-10 µM HOEC for 2 h and exposure to 600 µM H2O2. Additionally, glutathione reductase (GR), superoxide dismutase (SOD), lipid peroxidation malondialdehyde (MDA), and intracellular reactive oxygen species (ROS) accumulation were assayed after the PC12 cells were exposed to H2O2. To investigate mechanism, apoptosis-related protein were evaluated, including cleaved caspase 3/7, cleaved PARP, Bcl-2, Bcl-XL, and cytochrome c. The results showed that HOEC possessed potent antioxidant activity and pre-treatment with HOEC prior to H2O2 exposure significantly increased cell viability, reduced the release of LDH, ameliorated changes in cell morphology, and inhibited apoptosis. Further, HOEC did the following: reduced intracellular accumulation of ROS and MDA; rescued loss of SOD and GR activities; inhibited activated caspase-3 and caspase-7, cleaved PARP, and cytochrome c release; up-regulated the antiapoptosis-related protein Bcl-2 and Bcl-XL; and down-regulated the apoptosis-related proteins Bax and Bad. These findings suggested that HOEC may be a therapeutic agent for treating oxidative stress-derived neurodegenerative disorders.


Subject(s)
Caffeine/analogs & derivatives , Caffeine/pharmacology , Cell Survival/drug effects , Hydrogen Peroxide/toxicity , Animals , Apoptosis/drug effects , Apoptosis/physiology , Cell Survival/physiology , Dose-Response Relationship, Drug , Hydrogen Peroxide/antagonists & inhibitors , Oxidative Stress/drug effects , Oxidative Stress/physiology , PC12 Cells , Protective Agents/chemistry , Protective Agents/pharmacology , Rats , Reactive Oxygen Species/antagonists & inhibitors , Reactive Oxygen Species/metabolism
20.
Curr Med Chem ; 22(8): 975-88, 2015.
Article in English | MEDLINE | ID: mdl-25544641

ABSTRACT

The current pharmacological therapies for the treatment of Parkinson's disease are mostly inadequate and recent, improved therapeutic agents are required. Two important molecular targets for the design of anti-parkinsonian therapeutic compounds are the adenosine A2A receptor and the enzyme, monoamine oxidase (MAO) B. Adenosine A2A receptor antagonists are a relatively new class of anti-parkinsonian agents, which act by potentiating dopamine-mediated neurotransmission via dopamine D2 receptors. MAO-B inhibitors are established therapy of Parkinson's disease and inhibit the MAO-B-catalysed metabolism of dopamine in the brain. This conserves reduced dopamine stores and extends the action of dopamine. A2A antagonism and MAO-B inhibition have also been associated with neuroprotective effects, further establishing roles for these classes of compounds in Parkinson's disease. Interestingly, caffeine, a known adenosine receptor antagonist, has been recently considered as a lead compound for the design and discovery of A2A antagonists and MAO-B inhibitors. This review summarizes the recent efforts to discover caffeinederived MAO-B inhibitors. The design of caffeine-derived A2A antagonists has been extensively reviewed previously. The prospect of discovering dual-target-directed compounds that act at both targets is also evaluated. Compounds that block the activation and function of both A2A receptors and MAO-B may have a synergistic effect in the treatment of patients with Parkinson's disease.


Subject(s)
Adenosine A2 Receptor Antagonists/therapeutic use , Caffeine/analogs & derivatives , Caffeine/therapeutic use , Monoamine Oxidase Inhibitors/therapeutic use , Parkinson Disease/drug therapy , Adenosine A2 Receptor Antagonists/pharmacology , Animals , Caffeine/pharmacology , Drug Design , Humans , Monoamine Oxidase/metabolism , Monoamine Oxidase Inhibitors/pharmacology , Parkinson Disease/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...